Home > Financial Ratios > ASPIRA PATHLAB & DIAGNOSTICS

ASPIRA PATHLAB & DIAGNOSTICS
Price to Cash Earnings (PCE)

    Back to All Ratios
COMMUNITY POLL
for ASPIRA PATHLAB & DIAGNOSTICS
Please provide your vote to see the results

ASPIRA PATHLAB & DIAGNOSTICS Last 5 Year Price to Cash Earnings (PCE) History

[Consolidated]

Mar2025Mar2024
   PCE(x) 24.95-28.15

What is the latest Price to Cash Earnings (PCE) ratio of ASPIRA PATHLAB & DIAGNOSTICS ?

The latest Price to Cash Earnings (PCE) ratio of ASPIRA PATHLAB & DIAGNOSTICS is 24.95 based on Mar2025 Consolidated results.
Year Price to Cash Earnings (PCE)
Mar202524.95
Mar2024-28.15

How is Price to Cash Earnings (PCE) of ASPIRA PATHLAB & DIAGNOSTICS Trending?

Years Price to Cash Earnings (PCE) % Change
Mar2025 24.95
Positive
Mar2024 -28.15 -

Other Financial Ratios of ASPIRA PATHLAB & DIAGNOSTICS


Compare Price to Cash Earnings (PCE) ratio of peers of ASPIRA PATHLAB & DIAGNOSTICS

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
ASPIRA PATHLAB & DIAGNOSTICS ₹110.1 Cr -7.7% 1.7% 65.2% Stock Analytics
APOLLO HOSPITALS ENTERPRISE ₹129,126.0 Cr 1.8% 1.6% 17.6% Stock Analytics
MAX HEALTHCARE INSTITUTE ₹104,432.0 Cr -1.6% -2.5% -13.6% Stock Analytics
ASTER DM HEALTHCARE ₹75,861.6 Cr 6.9% 7.9% 39.5% Stock Analytics
FORTIS HEALTHCARE ₹72,476.0 Cr 1.7% 0.9% 9% Stock Analytics
NARAYANA HRUDAYALAYA ₹38,501.6 Cr -1.8% -5.3% -1.7% Stock Analytics


ASPIRA PATHLAB & DIAGNOSTICS Share Price vs Sensex


Share Price Returns(%) 1 Week 1 Month 1 Year
ASPIRA PATHLAB & DIAGNOSTICS

-7.7%

1.7%

65.2%

SENSEX

0.5%

2.6%

-3.7%


You may also like the below Video Courses